MicroGEM democratizes molecular biology by moving complex molecular biology tools out of highly skilled laboratories to non-laboratory settings where they can be used quickly at the point of need. The company’s innovative enzymatic approach to nucleic acid extraction provides the foundation for fast sample preparation suitable for PCR analysis. Coupled with its expertise in microfluidics and synthetic biology, MicroGEM is creating the next generation of person-portable diagnostic devices for the management of infectious diseases and other personalized medicine applications.

The company has received FDA emergency use authorization for the MicroGEM Sal6830 SARS-CoV-2 Saliva Test, the FDA’s first authorized saliva test for COVID-19 using PCR at the point of care. The test provides ‘saliva collection to PCR result’ in 27 minutes.


Lianne Landers

Phone Number

434 529 8212


Devices & Instrumentation

Company Stage


Company Size


Facility Size

7500 sq ft


705 Dale Avenue
Charlottesville, VA 22903

Related News